Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (257)
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
65
Price
$28.85
Total Value
$1.88K
Shares Held After
125,161
% of Holdings
0.1%
Whitehawk Therapeutics, Inc. (WHWK)
BALL BRYAN — Chief Technical Operations Officer and SVP, Manufacturing Operations
Shares
26,389
Price
$3.46
Total Value
$91.31K
Shares Held After
489,566
% of Holdings
5.1%
Disc Medicine, Inc. (IRON)
Savage William Jacob — Chief Medical Officer
Shares
2,200
Price
$66.81
Total Value
$146.98K
Shares Held After
79,480
% of Holdings
2.7%
Disc Medicine, Inc. (IRON)
Savage William Jacob — Chief Medical Officer
Shares
3,531
Price
$66.12
Total Value
$233.47K
Shares Held After
81,680
% of Holdings
4.1%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
530,610
Price
$16.15
Total Value
$8.57M
Shares Held After
3,404,998
% of Holdings
13.5%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
589
Price
$93.45
Total Value
$55.04K
Shares Held After
2,212,500
% of Holdings
0.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
2,564
Price
$92.79
Total Value
$237.91K
Shares Held After
2,213,089
% of Holdings
0.1%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
1,847
Price
$91.84
Total Value
$169.63K
Shares Held After
2,215,653
% of Holdings
0.1%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
1,686
Price
$38.20
Total Value
$64.41K
Shares Held After
184,558
% of Holdings
0.9%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
8,861
Price
$38.37
Total Value
$340.00K
Shares Held After
186,244
% of Holdings
4.5%
Liquidia Corp (LQDA)
Krepp Sarah — Chief Human Resource Officer
Shares
4,557
Price
$38.37
Total Value
$174.85K
Shares Held After
147,019
% of Holdings
3.0%
Liquidia Corp (LQDA)
Adair Jason — Chief Business Officer
Shares
7,301
Price
$38.37
Total Value
$280.14K
Shares Held After
215,426
% of Holdings
3.3%
Liquidia Corp (LQDA)
Schundler Russell — General Counsel
Shares
13,692
Price
$38.37
Total Value
$525.36K
Shares Held After
610,532
% of Holdings
2.2%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
32,744
Price
$38.37
Total Value
$1.26M
Shares Held After
1,137,599
% of Holdings
2.8%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
18,958
Price
$38.37
Total Value
$727.42K
Shares Held After
405,775
% of Holdings
4.5%
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
9,220
Price
$38.37
Total Value
$353.77K
Shares Held After
173,270
% of Holdings
5.1%
Liquidia Corp (LQDA)
Boyle Dana — Chief Accounting Officer
Shares
5,101
Price
$38.37
Total Value
$195.73K
Shares Held After
176,918
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$579.53
Total Value
$115.91K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
384
Price
$578.52
Total Value
$222.15K
Shares Held After
40,713
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,475
Price
$577.32
Total Value
$851.54K
Shares Held After
41,097
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,081
Price
$576.36
Total Value
$623.04K
Shares Held After
42,572
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,850
Price
$575.31
Total Value
$1.06M
Shares Held After
43,653
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,370
Price
$574.25
Total Value
$786.72K
Shares Held After
45,503
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,235
Price
$573.39
Total Value
$708.13K
Shares Held After
46,873
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
945
Price
$572.39
Total Value
$540.91K
Shares Held After
48,108
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
925
Price
$571.39
Total Value
$528.53K
Shares Held After
49,053
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
35
Price
$569.78
Total Value
$19.94K
Shares Held After
49,978
% of Holdings
0.1%
Rapport Therapeutics, Inc. (RAPP)
Yeleswaram Krishnaswamy — Chief Development Officer
Shares
9,165
Price
$34.97
Total Value
$320.54K
Shares Held After
276,851
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$580.03
Total Value
$23.20K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
400
Price
$579.04
Total Value
$231.62K
Shares Held After
18,916
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
601
Price
$577.93
Total Value
$347.33K
Shares Held After
19,316
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,603
Price
$577.01
Total Value
$924.95K
Shares Held After
19,917
% of Holdings
7.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,354
Price
$575.96
Total Value
$779.84K
Shares Held After
21,520
% of Holdings
5.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,457
Price
$575.06
Total Value
$837.86K
Shares Held After
22,874
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,860
Price
$574.00
Total Value
$1.07M
Shares Held After
24,331
% of Holdings
7.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,210
Price
$572.96
Total Value
$693.28K
Shares Held After
26,191
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,154
Price
$571.76
Total Value
$659.81K
Shares Held After
27,401
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$571.14
Total Value
$160.49K
Shares Held After
28,555
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$569.61
Total Value
$22.78K
Shares Held After
28,836
% of Holdings
0.1%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
33,171
Price
$6.41
Total Value
$212.76K
Shares Held After
49,849
% of Holdings
40.0%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
3,400
Price
$4.76
Total Value
$16.20K
Shares Held After
268,596
% of Holdings
1.3%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
1,000
Price
$4.76
Total Value
$4.76K
Shares Held After
271,996
% of Holdings
0.4%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
3,400
Price
$4.76
Total Value
$16.20K
Shares Held After
632,096
% of Holdings
0.5%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
1,014
Price
$4.76
Total Value
$4.83K
Shares Held After
635,496
% of Holdings
0.2%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
4,442
Price
$4.76
Total Value
$21.17K
Shares Held After
685,232
% of Holdings
0.6%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
4,399
Price
$4.76
Total Value
$20.96K
Shares Held After
3,707,569
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
3,338
Price
$14.08
Total Value
$47.00K
Shares Held After
421,174
% of Holdings
0.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
15,722
Price
$12.95
Total Value
$203.60K
Shares Held After
424,512
% of Holdings
3.6%
Alignment Healthcare, Inc. (ALHC)
KAO JOHN E — Director
Shares
82,299
Price
$20.80
Total Value
$1.71M
Shares Held After
1,806,641
% of Holdings
4.4%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$77.95
Total Value
$38.98K
Shares Held After
78,890
% of Holdings
0.6%
Showing 1–50 of 257 transactions (page 1 of 6)